Home › Funds › Farallon Capital Management › CRBU
Farallon Capital Management position in CRBU
CARIBOU BIOSCIENCES INC · Health Care
Latest position (Q3 2022)896.37K sh
Reported value held$9.46M
Portfolio Weight0.06%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.96M | $70.74M | New |
| Q4 2021 | 2.96M | $44.72M | Hold |
| Q1 2022 | 2.66M | $24.39M | Reduce |
| Q2 2022 | 2.20M | $11.97M | Reduce |
| Q3 2022 | 896.37K | $9.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CRBU
- BlackRock Inc 7.82M sh · $13.76M · Q2 2026
- Vanguard Group 4.30M sh · $6.84M · Q4 2025
- Renaissance Technologies 2.77M sh · $4.88M · Q2 2026
- Geode Capital Management 2.37M sh · $4.18M · Q2 2026
- Bank of America Corp 1.41M sh · $2.48M · Q2 2026
- Two Sigma Investments 1.05M sh · $1.84M · Q2 2026
- Charles Schwab Investment Management 775.81K sh · $1.37M · Q2 2026
- Fidelity Management & Research (FMR) 727.12K sh · $1.28M · Q2 2026
- Northern Trust Corp 712.97K sh · $1.25M · Q2 2026
- Maverick Capital 652.54K sh · $1.15M · Q2 2026
- UBS Group AG 517.37K sh · $910.57K · Q2 2026
- Marshall Wace 375.69K sh · $661.21K · Q2 2026